US Stock Movement | Revolution Medicines Surges Over 13% in After-Hours Trading Amid Reports of Acquisition Talks with Merck for Up to $32 Billion

格隆汇2026/01/09 01:23

Show original

By:格隆汇

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Glonghui, January 9th｜Biotechnology company Revolution Medicines (RVMD.US), focused on cancer drug development, surged over 13% in after-hours trading to $121.5. According to the Financial Times, citing sources familiar with the matter, Merck is in talks to acquire Revolution Medicines. The report states that the deal could be valued between $28 billion and $32 billion, and if finalized, it would be one of the largest pharmaceutical mergers since Pfizer's $43 billion acquisition of Seagen at the end of 2023. Previously, AbbVie denied that it was in negotiations to acquire Revolution Medicines.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Trump announced the formation of a federal "Artificial Intelligence Force" and the appointment of an AI affairs "chief," stating that AI could account for 25% of U.S. GDP. However, the responsibilities, funding, and leadership of the agency remain unclear, and its relationship with existing institutions is also uncertain. Internal White House advisors are divided on the extent of regulation, causing policy direction to be unstable.

华尔街见闻•2026/09/20 02:36

NEAR Protocol launches confidential perpetual futures, price breaks $2.827 resistance

Cointurk•2026/09/19 23:21